Imatinib mesylate (Gleevec(TM)) reduces phlebotomy requirements in polycythemia vera.
Overview
publication date
- June 1, 2003
published in
- Leukemia Journal
Research
keywords
- Enzyme Inhibitors
- Phlebotomy
- Piperazines
- Polycythemia Vera
- Pyrimidines
Identity
Scopus Document Identifier
- 0038717050
Digital Object Identifier (DOI)
- 10.1038/sj.leu.2402938
PubMed ID
- 12764388
Additional Document Info
has global citation frequency
volume
- 17
issue
- 6